SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · Entrada Therapeutics is holding a shareholder meeting to vote on the…

Entrada Therapeutics, Inc. · DEFA14A filed Apr 24, 2026 at 08:31 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 24, 2026 at 08:31 ET

Entrada Therapeutics is holding a shareholder meeting to vote on the election of directors, approval of the 2025 annual compensation program, and ratification of auditors. The filing is a definitive additional materials document, which is routine for an annual meeting.

  • Filing is a Definitive Additional Materials (DEFA14A) for an annual shareholder meeting.
  • Vote includes election of directors, approval of 2025 annual compensation program, and ratification of auditors.
  • No activist campaign or dissident filing; this is a routine management filing.
  • Recent insider activity shows minimal selling ($32K over 30 days).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access